Pathogens (May 2022)

Immunogenicity Analysis of the Recombinant <i>Plasmodium falciparum</i> Surface-Related Antigen in Mice

  • Jia-Li Yu,
  • Qing-Yang Liu,
  • Bo Yang,
  • Yi-Fan Sun,
  • Ya-Ju Wang,
  • Jian Jiang,
  • Bo Wang,
  • Yang Cheng,
  • Qiu-Bo Wang

DOI
https://doi.org/10.3390/pathogens11050550
Journal volume & issue
Vol. 11, no. 5
p. 550

Abstract

Read online

Plasmodium falciparum, mainly distributed in tropical and subtropical regions of the world, has received widespread attention owing to its severity. As a novel protein, P. falciparum surface-related antigen (PfSRA) has the structural and functional characteristics to be considered as a malaria vaccine candidate; however, limited information is available on its immunogenicity. Here, we expressed three fragments of recombinant PfSRA in an Escherichia coli system and further analyzed its immunogenicity. The results showed that rPfSRA-immunized mice produced specific antibodies with high endpoint titers (1:10,000 to 1:5,120,000) and affinity antibodies (i.e., rPfSRA-F1a (97.70%), rPfSRA-F2a (69.62%), and rPfSRA-F3a (91.87%)). In addition, the sera of immunized mice recognized both the native PfSRA and recombinant PfSRA, the rPfSRA antibodies inhibited the invasion of P. falciparum into the erythrocytes, and they were dose-dependent in vitro. This study confirmed PfSRA could be immunogenic, especially the F1a at the conserved region N-terminal and provided further support for it as a vaccine candidate against P.falciparum.

Keywords